Início › Colite ulcerativa › Carolina do Norte
Ensaios clínicos de Colite ulcerativa em Carolina do Norte
24 estudos para Colite ulcerativa estão buscando participantes em locais em Carolina do Norte.
Cidades em Carolina do Norte
- Durham11 estudos
- Charlotte7 estudos
- Fayetteville4 estudos
- Wilmington4 estudos
- Raleigh3 estudos
- Greenville3 estudos
Texto oficial do estudo (Inglês)
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Charlotte Gastroenterology and Hepatology, P.L.L.C, Charlotte
- Carolina Digestive Diseases, Greenville
- Piedmont Healthcare, Statesville
- e mais 1
RecrutandoFase 4
Idades de 18 a 80 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06581328A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- University of North Carolina, Chapel Hill
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06598943Confirmatory Clinical Study in Active Ulcerative Colitis
- Cross Creek Medical Clinic, Fayetteville
- Peters Medical Research, High Point
RecrutandoFase 2
Idades 16 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07296315A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- 040, Chapel Hill
- Site 041, Durham
- Site 016, Winston-Salem
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07012395Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Raleigh
RecrutandoFase 1/2Voluntários saudáveis bem-vindos
Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06619990Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Digestive Health Partners /ID# 280490, Asheville
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07697456A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Monroe Biomedical Research, Monroe
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06979336A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- University of North Carolina, Chapel Hill
- Atrium Health, Charlotte
RecrutandoFase 3
Idades 12 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Coastal Research Institute - Fayetteville, Fayetteville
RecrutandoFase 3
Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06937086LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Carolina Digestive Diseases and Endoscopy Center, Greenville
- Wilmington Health, PLLC, Wilmington
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Digestive Health Partners, Asheville
- University of North Carolina, Chapel Hill
RecrutandoFase 4
Idades de 18 a 65 · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Cross Creek Medical Clinic - Site Number: 8400057, Fayetteville
RecrutandoFase 3
Idades de 16 a 80 · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07185009A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- University of North Carolina at Chapel Hill, Chapel Hill
RecrutandoFase 4
Idades 18 e acima · Mulheres · Atualizado em 28 de ago. de 2026 · NCT07654751A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Atrium Health Gastroenterology and Hepatology, Charlotte
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- UNC Hospitals, The University of North Carolina at Chapel Hill - Site Number: 8400074, Chapel Hill
- OnSite Clinical Solutions - Site Number: 8400051, Charlotte
- Duke University Medical Center - Site Number: 8400093, Durham
- e mais 3
RecrutandoFase 3
Idades de 16 a 80 · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07184996BOOM-IBD2 Pivotal Clinical Trial
- UNC Chapel Hill, Chapel Hill
Recrutando
Idades de 18 a 85 · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT06571669Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of North Carolina, Chapel Hill
- Atrium Health Center for Gastroenterology and Surgery, Charlotte
- Wake Forest School of Medicine, Winston-Salem
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT07237516An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill
- OnSite Clinical Solutions, LLC, Charlotte
RecrutandoEstudo observacional
Idades de 18 a 64 · Todos os sexos · Atualizado em 9 de jul. de 2026 · NCT06398626A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
- PPD Virtual - PPD - US, Wilmington
RecrutandoEstudo observacional
Todas as idades · Mulheres · Atualizado em 15 de jun. de 2026 · NCT05953402A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400002, Chapel Hill
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 23 de abr. de 2026 · NCT06975722A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, High Point
- Mirador Therapeutics Selected Site, Raleigh
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 12 de mar. de 2026 · NCT07113522Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 010, Greenville
RecrutandoFase 4
Idades de 5 a 17 · Todos os sexos · Atualizado em 16 de set. de 2025 · NCT04314375Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- University of North Carolina, Chapel Hill
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 8 de mai. de 2025 · NCT06750731IBD Pregnancy Registry
- PPD, Wilmington
RecrutandoEstudo observacional
Idades de 18 a 50 · Mulheres · Atualizado em 4 de abr. de 2025 · NCT06910553Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.